High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer
Abstract Between 5 and 8% of the general population carry a constitutional methylation of the BRCA1 promoter (“epimutation”). Several studies have suggested that these BRCA1 epimutations confer an increased risk of breast cancer, in particular triple-negative breast cancer (TNBC), with an earlier on...
Saved in:
| Main Authors: | Mathias Schwartz, Sabrina Ibadioune, Hélène Delhomelle, Solenn Barraud, Sandrine M. Caputo, Olfa Trabelsi-Grati, Marie-Charlotte Villy, Anthony Laugé, Roseline Tang, Etienne Rouleau, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Éric Pasmant, Lisa Golmard, Chrystelle Colas, Ivan Bièche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Clinical Epigenetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13148-025-01885-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter
by: Hélène Delhomelle, et al.
Published: (2025-07-01) -
MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas
by: Oleksii Nikolaienko, et al.
Published: (2025-02-01) -
Introduction of epigenetic variation contribute to resistance against the human parasite Schistosoma mansoni
by: Nelia Luviano-Aparicio, et al.
Published: (2025-07-01) -
Genetic counseling for hereditary cancer syndromes: a 5-year experience from a single center in Bulgaria
by: Mari Hachmeriyan, et al.
Published: (2025-07-01) -
PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
by: Bingting Li, et al.
Published: (2023-12-01)